Kaleido Biosciences, Inc. (KLDO) Social Stream



Kaleido Biosciences, Inc. (KLDO): $0.00

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add KLDO to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#378 of 443

in industry

KALEIDO BIOSCIENCES INC (KLDO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering KALEIDO BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $22 $3 $14.75 $0.15 9733.33%
2021-12-06 5 $22 $3 $13.75 $0.15 9066.67%
2022-01-30 5 $22 $3 $10 $0.15 6566.67%
2022-01-31 5 $22 $3 $8 $0.15 5233.33%
2022-04-04 2 $22 $1.7 $11.85 $0.15 7800%

The Trend in the Analyst Price Target


Over the past 43 weeks, KLDO's average price target has gone down $8.46.

KLDO reports an average of 254.11% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 3 30 6.0 16.570 6.68 148.05%
2021-09-19 7 25 12.0 18.000 5.83 208.75%
2021-09-20 7 25 12.0 18.000 5.64 219.15%
2021-12-06 5 22 3.0 13.750 3.24 324.38%
2022-04-04 2 22 1.7 7.675 1.64 367.99%

KLDO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 0 0 1 1 2

The Trend in the Broker Recommendations


Over the past 26 weeks, KLDO's average broker recommendation rating worsened by 0.5.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KLDO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, KALEIDO BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 699.93% of them.
  • In the context of all US stocks, KALEIDO BIOSCIENCES INC's variance in analysts' estimates is lower than -589.6% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, KALEIDO BIOSCIENCES INC's average analyst price target is higher than 129.27% of them.
  • In terms of how KALEIDO BIOSCIENCES INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 200.63% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KALEIDO BIOSCIENCES INC are JSPR, JNCE, and ITOS.

Is KLDO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!